Ying Cong Selected Research

propane-2-sulfonic acid octadec-9-enyl-amide

10/2020	Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, reverses neuroinflammation in lipopolysaccharide-induced mice.
1/2020	Propane-2-sulfonic acid octadec-9-enyl-amide alleviates scopolamine-induced spatial learning and memory deficits in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Cong Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2020
2	COVID-19 01/2021 - 01/2020
2	Infections 05/2019 - 01/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Disease Progression 11/2020
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Neuroinflammatory Diseases 10/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2020
1	Ischemic Stroke 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Cognitive Dysfunction 01/2020
1	Adenocarcinoma of Lung 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Hemolysis 03/2016

Drug/Important Bio-Agent (IBA)

2	propane-2-sulfonic acid octadec-9-enyl-amideIBA 10/2020 - 01/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2020 - 01/2020
1	Teniposide (VM 26)FDA Link 01/2021
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Tyrosine Kinase InhibitorsIBA 11/2020
1	Adenosine (Adenocard)FDA LinkGeneric 11/2020
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	EnzymesIBA 11/2020
1	LipopolysaccharidesIBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	Protective AgentsIBA 10/2020
1	FibrinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2020
1	CollagenIBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	Bexarotene (LGD1069)FDA Link 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	SiderophoresIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Ubiquitin-Conjugating EnzymesIBA 01/2018
1	AlloysIBA 03/2016

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 11/2020
1	Intraperitoneal Injections 01/2020